- American City Business Journals•10 days ago
Philadelphia-area biotech, specialty pharmaceutical and generic drug company stocks got hammered Wednesday after President-elect Donald Trump criticized the industry for manufacturing drugs outside of the U.S. and charging excessive prices. “We’re the largest buyer of drugs in the world, but we don’t bid properly, and we’ll save billions over time and we’ll do that with a lot of other industries,” Trump said at his first news conference since July. Among the local drug company stocks taking the biggest hits Wednesday were Discovery Labs (DSCO), which dropped more than 9 percent in mid-afternoon trading, and Endo International (ENDP).
- PR Newswire•9 months ago
"Today marks a new direction in the pursuit of our mission to save and improve lives, beginning with the care of the most fragile of patients – premature infants. As we look to the future, it seems only fitting that recent changes in our leadership and approach be coupled with a name and image most reflective of our laser focus on respiratory disease, our commitment to patients, and our determination to build a valuable venture," commented Craig Fraser, Chief Executive Officer. The name Windtree brings to mind a number of impressions that resonate strongly within the respiratory space. "Wind" signifies breath, air and motion, while reinforcing the ideas of dynamism and change. "Tree" signifies the lungs, long life, strength, and growth. The bringing together of the two words is intended to capture the energy and character of this unique Company as it begins an important new phase of its evolution.
- Accesswire•9 months ago
MIAMI, FL / ACCESSWIRE / April 11, 2016 / Top Nasdaq Stocks is issuing a report on four stocks to watch. EGLE, COOL, DSCO, and CRBP have been added to our watch list today. Continue reading to find out ...
Requested symbol wasn't found
NasdaqCM . Currency in USD
Add to watchlist
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|